There is no doubt going to be competition in the near
There is no doubt going to be competition in the near future for therapeutics.
The question is: will the therapeutics show efficacy in the severe/critical population? Regeneron or Eli Lily’s drug may reduce the number of patients who progress to the severe/critical category but there will still be patients who don’t respond to these medications and progress to the ICU and mechanical ventilation. That’s hopefully where leronlimab fits into the therapeutic equation for COVID19, although I think there’s a reason to argue that leronlimab May also prevent progression to the severe/critical category based on the NEWS2 data from the M2M trial.
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Bunge Limited Faces Market Pressures as Stock Prices Decline In a year characterized by considerable market fluctuations, Bunge Limited (NYSE: BG) has seen its stock reach a concerning 52-week low of $77.52. With an attractive price-to-earnings (P/E) ratio of 9.7 and a commendable dividend yield of 3.48%, Bunge has consistently paid dividends for an impressive 24 years,...
Continue Reading
Upcoming Market Highlights to Observe As we look ahead, several significant events are poised to influence market dynamics. As corporate earnings season blossoms, attention will focus on major players in tech, finance and energy sectors. Global leaders are gathering to discuss critical economic issues, all while fluctuating oil prices add to the tension. Let's explore...
Continue Reading
Touchmark Bancshares, Inc. just cut ties with the Office of the Comptroller of the Currency (OCC) on February 17, 2026, after a lengthy 22-month oversight period. This enforcement action was slapped on them back in April 2024, and it seemed like a cloud hanging over their heads for ages. Traders were watching closely—this termination isn’t just a footnote; it speaks...
Continue Reading
Bybit Kicks Off an Innovative WSOT 2025 Bybit, a leading player in the cryptocurrency exchange arena, is taking bold steps to redefine the World Series of Trading (WSOT) in its upcoming 2025 edition. Known for hosting the longest-running crypto trading competition globally, Bybit is set to catapult this event into a new era, offering a staggering 10 million USDT prize...
Continue Reading
Brookfield Corporation to Host Second Quarter 2025 Results Conference Call BROOKFIELD, NEWS — Brookfield Corporation (NYSE: BN) will host its second quarter 2025 conference call and webcast on Thursday, August 7, 2025, at 10:00 AM (ET). Key Information and Joining Details Results from the financial quarter will be released that morning around 7:00 AM (ET) and will be...
Continue Reading
